HCA Healthcare lowered its full-year earnings outlook amid a deteriorating payer mix and cost pressures. Diluted EPS for 2026 is expected to be $28.70-$30.50, with an increase in uninsured patients and changes in Medicaid supplemental payments cited as contributing factors.
HCA Healthcare said that a deteriorating payer mix and intense cost pressures are directly affecting margins, and lowered its full-year earnings outlook. Management pointed to a possible impact on 2026 EPS from an increase in uninsured patients and changes in Medicaid supplemental payments.
Under the new outlook, diluted earnings per share (EPS) for 2026 are projected at $28.70-$30.50. The focus now is on whether the initial investment thesis can be sustained, depending on the effects of cost-cutting measures and operational reforms.
The company presented a scenario projecting revenue of $88.7 billion and net income of $7.2 billion by 2029. Achieving this would require annual revenue growth of 4.4% and an increase in profit of approximately $400 million from current levels.
From a market perspective, attention will remain focused on the impact of sharp changes in the payer mix on margins and cash flow, while the possibility of a different outcome also remains.